Campus de Bellvitge

UDG UDG

Campus de Bellvitge

Campus de Bellvitge > Teachers > Gerard Muñoz

Gerard Muñoz

Gerard Muñoz
Director of Physiotherapy

EDUCATION / TRAINING:

  • Acredited lecturer (AQU) since 2021
  • Acredited researcher (AQU) since 2022
  • PhD in Universitat Autonoma de Barcelona 2017.
  • Master of Science in Respiratory Medicine in Universitat de Barcelona 2010-2011
  • Post-degree in Thorax physiotherapy in Universitat Gimbernat, Barcelona 2009-2010.
  • University Degree: Universitat de Blanquerna 2000-2003. 

ACADEMIC POSITIONS

  • Associate Lecturer in Respiratory Physiotherapy. Universitat de Girona. From September 2008.
  • Head of Department Degree in Physiotherapy UB-UdG From December 2020

PROFESSIONAL POSITIONS

  • Respiratory Physiotherapist and Researcher, Girona Biomedical Research Institute. Pneumology department in Dr Trueta University Hospital.

RESEARCH LINES

  • Bronchiectasis & Cystic Fibrosis
  • Airway clearance techniques
  • Pulmonary rehabilitation 

PUBLICATIONS (Last ten years)

  • Herrero-Cortina B, Lee AL, Oliveira A, O’Neill B, Jácome C, Dal Corso S, Poncin W, Muñoz G, Inal-Ince D, Alcaraz-Serrano V, Reychler G, Bellofiore A, Posthumus A; Patient representative; Tonia T, Chalmers JD, Spinou A. European Respiratory Society statement on airway clearance techniques in adults with bronchiectasis. Eur Respir J. 2023;62(1):2202053. doi: 10.1183/13993003.02053-2022.
  • Herrero-Cortina B, Spinou A, Oliveira A, O’Neill B, Jácome C, Dal Corso S, Poncin W, Muñoz G, Inal-Ince D, Alcaraz-Serrano V, Reychler G, Bellofiore A, Posthumus A; Patient representative; Chalmers JD, Lee AL. Airway clearance techniques and exercise in people with bronchiectasis: two different coins. Eur Respir J. 2023 Oct 12;62(4):2300741. doi: 10.1183/13993003.00741-2023. PMID: 37827549.
  • Cazorla-González J, García-Retortillo S, Gacto-Sánchez M, Muñoz-Castro G, Serrano-Ferrer J, Román-Viñas B, López-Bermejo A, Font-Lladó R, Prats-Puig A. Effects of Crawling before Walking: Network Interactions and Longitudinal Associations in 7-Year-Old Children. Int J Environ Res Public Health. 2022 May 3;19(9):5561. doi: 10.3390/ijerph19095561. PMID: 35564955; PMCID: PMC9100207.
  • Muñoz Castro G, Balañá Corberó A. Airway Clearance and Mucoactive Therapies. Semin Respir Crit Care Med. 2021 Aug;42(4):616-622. doi: 10.1055/s-0041-1730922. Epub 2021 Jul 14. PMID: 34261185.
  • Muñoz G, de Gracia J, Giron R, Olveira C, Alvarez A, Buxó M, Birring SS, Vendrell M. Validation of a Spanish version of the Leicester Cough Questionnaire in cystic fibrosis. Chron Respir Dis. 2021 Jan-Dec;18:14799731211036903. doi: 10.1177/14799731211036903. PMID: 34730449;
  • Rodrigues A, Muñoz G, Jácome C, Langer D, MP Selina and Burtin C. Current developments and future directions in respiratory physiotherapy. Eur Respir Rev 2020; 29: 200264 [https://doi.org/10.1183/ 16000617.0264-2020].
  • Polverino E, Rosales-Mayor E, Benegas M, Menendez R, Alcaraz-Serrano V, Ansotegui E, Montull B, Girón RM, Cisneros C, Vendrell M, Muñoz G, Marcos MA, Sanchez M, Torres A. Pneumonic and non-pneumonic exacerbations in bronchiectasis: Clinical and microbiological differences. J Infect. 2018;77(2):99-106. doi: 10.1016/j.jinf.2018.04.006.
  • Muñoz G, de Gracia J, Buxó M, Alvarez A, Vendrell M. Long-term benefits of airway clearance in bronchiectasis: a randomized placebo-controlled trial. Eur Respir J 2018. 11;51(1).
  • Muñoz G, Buxó M, de Gracia J, Olveira C, Martinez-Garcia MA, Giron R, Polverino E, Alvarez A, Birring S, Vendrell M. Validation of a Spanish versión of the Leicester cough questionnaire in Non-cystic fibrosis bronchiectasis. Chron Respir Dis. 2016 May;13(2):128-36. doi: 10.1177/1479972316632005
  • Vendrell M, Muñoz G, de Gracia J. Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. The Open Respiratory Medicine Journal 2015;9:30-36
  • Olveira C, Olveira G, Espildora F, Giron R, Muñoz G, Quittner A, Martinez-Garcia MA. Validation of a patient-reported outcome measure for bronchiectasis: Psychometric analyses of the Spanish QOLB-V3.0. Qual Life Res. 2014;23:1279-92.
  • Vendrell M, Muñoz G, Sabater G. El futuro de la antibioterapia inhalada. Nuevos productos.Arch Bronconeumol. Arch Bronconeumol. 2011;47(Supl 6):30-32

RESEARCH  GRANTS AND COLLABORATION

Research Collaboration

  • “Estudio Aztreonam: A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Repeated Courses of Aztreonam for Inhalation Solution/Aztreonam 75 mg Powder and Solvent for Nebuliser Solution in Subjects with non-CF Bronchiectasis and Gram-Negative Endobronchial Infection (AIR-BX2).” Predoc Fellow.
  • “Estudio calidad de vida: Prevalencia e impacto de los síntomas de depresión y ansiedad en la calidad de vida de pacientes con bronquiectasias no Fibrosis Quística (FQ).” Investigator
  • “Estudio ejercicio: Elaboración de las ecuaciones de referencia para las pruebas de marcha de 6 minutos y de lanzadera (shuttle test) en población española adulta.” Investigator
  • “Estudio EXAPOC: Impacto del número y gravedad de las exacerbaciones en el curso clínico de la EPOC.” Predoc Fellow.
  • “Estudio Orbit 3: Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo para evaluar la seguridad y la eficacia de Pulmaquin® en el tratamiento de infecciones pulmonares crónicas por Pseudomonas aeruginosa en sujetos con bronquiectasia no debida a fibrosis quística, incluida la extensión abierta de 28 días y el subestudio farmacocinético (Orbit 3).” Investigator
  • “Estudio agudizaciones: “Epidemiología y caracterización clínica-microbiológica de las agudizaciones en las Bronquiectasias no asociadas a fibrosis quística”. Investigator
  • “Estudio EMBARC: “El registro europeo de bronquiectasias”.” Investigator
  • “Estudio INSMED: “A Phase 2, Double-Blind, Placebo-Controlled, Three Parallel Groups Study to Determine the Efficacy, Safety and Tolerability, and Pharmacokinetics of INS1007 Once Daily in Subjects with Non-Cystic Fibrosis Bronchiectasis” Investigator

“He actively participates as a speaker/moderator in different national and international respiratory specialty conferences since 2011”


gmunoz@euses.cat Estudis: International Degree in Physiotherapy
Assignatures: Cardiorespiratory Pathology (3rd), Respiratory Physiotherapy and Cardiac Rehabilitation (3rd); Practicum II (4th); Final Project (4th)
OUR CAMPUS
Take a tour of our Campus, where you will find
the best specialised and continuous training in health and sport.
EUSES
Campus de Bellvitge
Carrer de la Feixa Llarga s/n.
08907 L’Hospitalet de Llobregat (Barcelona)
T. 932 63 02 24
physiotherapy@euses.cat
Master’s Degrees
© 2023 ® Euses Escola Universitària de la Salut i l’Esport. Learning centre attached to the University of Girona and the Rovira i Virgili University
×ATENCIÓ: Cookies no configurades en l'idioma actual. Revisa la teva configuració al plugin, gràcies!
Do you want more information?